Highlighting the extensive and cancer-specific expression pattern of genes encoding beta-hCG, Chew et al. developed a cancer-specificity scoring metric to screen for cancer-specific genes expressed across multiple cancer types and identified CGB5, one of the genes encoding beta-hCG proteins, as the gene exhibiting the strongest pan-cancer signal (Chew et al., 2019). This evidence concerns the gene CGB5 and cancer.